Prophylaxis of hepatitis C with intramuscular immunoglobulin: Clinical and economic appraisal

BioDrugs

Volumn 12, Issue 4, 1999, Pages 291-300

  Piazza, Marcello ^a   Sagliocca, Luciano ^b   Tosone, Grazia ^a   Guadagnino, Vincenzo ^e   Stazi, Maria Antonietta ^c   Orlando, Raffaele ^a   Borgia, Guglielmo ^a   Rosa, Domenico ^d   Abrignani, Sergio ^d   Palumbo, Filippo ^e   Manzin, Aldo ^e   Clementi, Massimo ^e  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b Regione Campania   (Italy)

^c ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^d CHIRON VACCINES   (Italy)

^e NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYPERIMMUNE GLOBULIN; IMMUNOGLOBULIN; NEUTRALIZING ANTIBODY;

BLOOD TRANSFUSION; CHRONIC LIVER DISEASE; CLINICAL TRIAL; DRUG MANUFACTURE; ECONOMIC ASPECT; HEALTH CARE COST; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; IMMUNOTHERAPY; INTRAMUSCULAR DRUG ADMINISTRATION; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEXUAL TRANSMISSION; VIRUS TRANSMISSION;

EID: 0032711210     PISSN: 11738804     EISSN: None     Source Type: Journal    
DOI: 10.2165/00063030-199912040-00006     Document Type: Review

References (75)

1. National Institutes of Health Consensus Development Conference Panel Statement. Management of hepatitis C. Hepatology 1997; 26 Suppl. I: 2S-10S
2. Davis GI, Treatment of acute and chronic hepatitis C. In: Davis GI, editor. Clinics in liver disease. Philadelphia (PA): W.B. Saunders Company, 1997: 615-30
3. Alter MJ. Epidemiology of hepatitis C. Hepatology 1997; 26 Suppl. I: 62S-5S
4. Heintges T, Wands JR. Hepatitis C virus: epidemiology and transmission. Hepatology 1997; 26: 521-6
5. Sharara AI, Hust CM, Hamilton JD. Hepatitis C. Ann Intern Med 1996; 125: 658-68
6. Hoofnagie HJ. Hepatitis C: the clinical spectrum of disease. Hepatology 1997: 26 Suppl. I: 15S-20S
7. Secff LB. Natural history of hepatitis C. Hepatology 1997; 26 Suppl. 1: 21-8S
8. Di Bisceglie AM, Hepatitis C and hepatocellular carcinoma. Hepatology 1997; 26 Suppl. I: 34S-8S
9. Piazza M, Cacciatore L, Molinari V, et al. Hepatitis B not transmissible via fecal-oral route. Lancet 1975; II: 706-7
10. US Department of Health, Education, and Welfare. Hepatitis surveillance III. In: Hepatitis B transmission modes: evidence against enteric transmission, report 41. Atlanta (GA): Centers for Disease Control, 1977: 20-2
11. Alter MJ. The detection, transmission, and outcome of hepatitis C virus, Infect Agents Dis 1993; 2: 155-66
12. Dienstag JL, Sexua1 and perinatal transmission of hepatitis C. Hepatology 1997; 26 Suppl. I: 66S-70S
13. Everhart JE, Di Bisceglie AM, Murray LM, et al. Risk for non-A, non-B (type C) hepatitis through sexual or household contact with chronic carriers. Ann Intern Med 1990; 112 (7): 544-6
14. Pcano GM, Fenoglio LM, Menardi G, et al. Heterosexual transmission of hepatitis C virus in family groups without risk factors. BMJ 1992; 305: 1473-4
15. Akahane Y, Aikawa T, Sugai Y, et al. Transmission of HCV between spouses. Lancet 1992; 339: 1059-60
16. Kao J-H, Chon PJ, Yang P-M, et al. Intratamilial transmission of hepatitis C virus: the important role of infection between spouses. J Infect Dis 1992; 166; 900-3
17. Rice PS, Smith DB, Simmonds P, et al. Heterosexual transmission of hepatitis C virus. Lancet 1993; 342: 1052-3
18. Honda M, Kaneko S, Unoura M, et al. Risk of hepatitis C virus infections through household contact with chronic carriers: analysts of nucleotide sequences. Hepatology 1993; 17; 971-6
19. Osmond DH, Padian NS, Sheppard HW, et al. Risk factors for hepalitis C virus seropositivity in heterosexual couples. JAMA 1993; 269; 361-5
20. Bresters D, Mauser-Bunscholen EP, Reesink HW. Sexual transmission of hepatitis C virus. Lancet 1993; 342: 210-1
21. Hallam NF, Fletcher ML, Read SJ, et al. Low risk of sexual transmission of hepatitis C virus. J Med Virol 1993; 40: 251-3
22. Chang T-T, Liou T-C, Young K-C, et al. Intrafamilial transmission of hepatitis C virus: the important role of inapparent transmission. J Med Virol 1994; 42: 91-6
23. Ideo G, Bellati G, Pedraglio E, et al. Intrafamilial transmission of hepatitis C virus [letter]. Lancet 1990; 335 (8685): 353
24. Akahane Y, Kojima M, Sugai Y et al. Hepatitis C virus infection in spouses of patients with type C chronic liver disease. Ann Intern Med 1994; 120: 748-52
25. Mauser-Bunschoten EP, Bresters D, Reesink HW. Transmission of hepatitis C virus to spouses. Ann Intern Med 1995; 122: 154-5
26. McGovern TW, Holtzmuller KC, Sherman KE, et al. Hepatitis C virus infections in U.S. families. In: Nishioka K, Suzuki H, Mishiro S, et al., editors. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 450-4
27. Ohmo T, Mizokama M, Lau IYN, et al. Sexual transmission of hepatitis C virus. In: Nishioka K, Suzuki H, Mishiro S, et al., editors. Viral hepatitis and liver disease. Tokyo: Springer-Verlag, 1994: 455-8
28. Setoguchi Y, Kajihara S, Hara T, et al. Analysis of nucleotide sequences of hepatitis C virus isolates from husband-wife pairs. J Gastroenterol Hepatol 1994; 9: 468-71
29. Chayama K, Kobayashi M, Tsubota A, et al. Molecular analysis of intraspousal transmission of hepatitis C virus. J Hepatol 1995; 22: 431-9
30. Kao J-H, Hwang Y-T. Chen P-J, et al. Transmission of hepatitis C virus between spouses: the important role of exposure duration. Am J Gastroenterol 1996; 91: 2087-90
31. Capelli C, Prati D, Bosoni P, et al. Sexual transmission of hepatitis C virus to a repeat blood donor. Transfusion 1997; 37 (4): 436-40
32. Salleras L, Bruguera M, Vidal J, et al. Importance of sexual transmission of hepatitis C in seropositive pregnant women: a case-control study. J Med Virol 1997; 52: 164-7
33. Alter HJ, Conry-Cantilena C, Meldpolder J, et al. Hepatitis C in asymptomatic blood donors. Hepatology 1997; 26 Suppl. I: 29S-33S
34. Caporaso N, Ascione A, Stroffolini T, Investigators of an Italian Multicenter Group. Spread of hepatitis C virus infection within families. J Viral Hepatitis 1998; 5: 67-72
35. Piazza M, Sagliocca L, Tosone G, et al. Sexual transmission of the hepatitis C virus and efficacy of prophylaxis with intra-muscular immune serum globulin. A randomized controlled trial. Arch Intern Med 1987; 157: 1537-44
36. Koff RS. Prevention of hepatitis C virus infection. In: Davis GL, editor. Clinics in liver disease. Philadelphia (PA): W.B. Saunders Company, 1997: 603-13
37. U.S. Department of Health and Human Services. Centers for Disclose Control and Prevention. Recommendations for prevention and control of hepatitis C virus (HCV) infection and HCV-related chronic disease. MMWR Morb Mortal Wkly Rep 1998; 47 (RR-19): 1-39
38. Knodell RG, Conrad ME, Ginsberg AL, et al. Efficacy of prophylactic gamma-globulin in preventing non-A. non-B post-transfusion hepatitis. Lancet 1976; I: 557-61
39. Kuhns WJ, Prince AM, Brotman B, et al. A clinical and laboratory evaluation of immune serum globulin from donors with a history or hepatitis: attempted prevention of post-transfusion hepatitis. Am J Med Sci 1976; 272: 255-61
40. Seeff LB, Zimmerman HJ, Wright EC, et al. A randomized, double blind controlled trial of the efficacy of immune serum globulin for the prevention of post-transfusion hepatitis. Gastroeznterology 1977: 72: 111-21
41. Knodell RG, Conrad ME, Ishak KG. Development of chronic liver disease after acute non-A, non-B post-transfusion hepatitis. Role of γ-globulin prophyhtaxis in its provention. Gastroenterology 1977; 72: 902-9
42. Sanchez-Quijann A, Pineda JA, Lissen E, et al. Prevention of post-transfusion non-A, non-B hepatitis by non-specific immunoglobulin in heart surgery patients. Lancet 1988; 1: 1245-9
43. al-Khaja N, Roberts DG, Belboul A, et al. Gamma globulin prophylaxis to reduce post-transfusion non-A, non-B hepatitis after cardiac surgery with cardiopulmonary bypass. Scand J Thor Cardiovase Surg 1991; 25; 7-12
44. Seeff LB, Hoofnagle JH. Immunoprophylaxis of viral hepatitis, Gastroenterology 1979, 77: 161-82
45. Sugg U, Schneider W, Hoffmeister HE, et al. Hepatitis B immune globulin to prevent non-A, non B post-transfusion hepatitis. Lancet 1985; 1: 405-6
46. Simm N. Prevention of non-A, non-B hepatitis in haemodialysis patients by hepatitis B immunoglubulin. Lancet 1984; II: 1047
47. Conrad ME, Lemon SM. Prevention of endemic icteric viral hepatitis by administration of immune serum gamma globulin. J Infect Dis 1987: 156: 56-63
48. van der Poel CL, Cuypers HT, Reesink HW. Hepatitis C virus six years on. Lancet 1894; 344: 1475-9
49. Jarvis LM, Watson HG, McOmish F, et al. Frequent reinfection and reactivation of hepatitis C virus genotypes in multitransfused haemophiliacs. J Infect Dis 1994; 170: 1018-22
50. Lai ME, Mazzoleni AP, Argiolu F, et al. Hepatitis C virus in multiple episodes of acute hepatitis in polytransfused thalessemic children. Lancet 1994; 343: 388-90
51. Farci P, Alter HJ, Govindarajan S, et al. Lack of protective immunity against reinfection with hepatitis C virus. Science 1992; 258: 135-40
52. Choo Q-L, Kuo G, Ralston R, et al. Vaccination of chimpanzecs against infection by the hepatitis C virus. Proc Natl Acad Sci USA 1994; 91: 1294-8
53. Farci P, Alter HJ, Wong DC, et al. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 1994: 91: 7792-96
54. Farci P, Shimoda A, Wong D, et al. Prevention of HCV infection in chimpanzees by hyperimmune serum against the hypervariable region (HVRI): emergence of neutralization escape mutants in vivo [abstract]. Hepatology 1995; 22 (Pt 2): 220
55. Piazza M, Chien D, Quan S, Houghton M. Lack of antibodies to the envelope glycoproteins of hepatitis C virus in immunoglobulin preparations from screened donors. J Biol Res - Boll Soc It Biol Sper 1996; 72: 69-70
56. Pileri P, Uematsu Y, Campagnoli S, et al. Binding of hepatitis C virus to CD81. Science 1998; 282: 938-41
57. Krawczynski K, Alter MJ, Tankersley DL, et al. Effect of Immune globulin on the prevention of experimental hepatitis C virus infection. J Infect Dis 1996; 173: 822-8
58. Yu MW, Guo ZP, Mason BL, et al. Presence of protective antibodies in an experimental intravenous immune globulin prepared from anti-HCV positive donor units [abstract no. H13]. 5th International Meeting on Hepatitis C Virus and Related Viruses: 1998 Jun 25-28; Venice, 223
59. Krawezynski K, Fattom A, Sapan C, et al. Experimental treatment of HCV infection: passive anti-HCV transfer in acutely infected chimpanzees [abstract SS5/28]. 34th Annual Meeting of European Association for the Study of Liver: 1999 Apr 8-12; Naples, 59
60. Feray C, Gigou M, Samuel D, et al. Incidence of hepatitis C in patients receiving different preparations of hepatitis B immunoglobulins after liver transplantation. Ann Intern Med 1998; 128: 810-6
61. Ishii K, Rosa D, Watanabe Y, et al. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C. Hepatology 1998; 28: 1117-20
62. Pessoa MG, Wright TL, Hepatitis C infection in transplantation. In: Davis GL, editor. Clinics in liver disease. Philadelphia (PA): W.B. Saunders Company, 1997: 663-90
63. Dusheiko GM, Roberts JA. Treatment of chronic type B and C hepatitis with interferon alfa: an economic appraisal. Hepatology 1995: 22: 1863-73
64. Koff RS. Therapy of hepatitis C: cost-effectiveness analysis. Hepatology 1997; 26 Suppl. 1: 152S-5S
65. Bennett WG, Inoue Y, Beck JR, et al. Estimates of the cost-effectiveness of a single course of interferon-α2b in patients with histologically mild chronic heparitis C. Ann Intern Med 1997; 127: 855-65
66. Kim WR, Poterucha JJ, Hermans JE, et al. Cost-effectiveness of 6 and 12 months of interferon-α therapy for chronic hepatitis C. Ann Intern Med 1997; 127: 866-74
67. Piazza M. Immunoglobulin transmits hepatitis C. True or false? Hepatology 1999; 29: 299-300
68. Centers for Disease Control. Recommendations of the Immunization Practices Advisory Committee (ACIP). Recommendations for protection against viral hepatitis. MMWR Morb Mortal Wkly Rep 1985; 34 (22): 313-35
69. Centers for Disease Control. Prevention of hepatitis A through active or passive immunization: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 1996; 45 (RR-15): 1-30
70. World Health Organization memoranda. Public health control of hepatitis A: memorandum from a WHO meeting. WHO Bull 1995, 73 (1): 15-20
71. Piazza M, Sagliocca L, Tosone G et al. More evidence tm salary of intramuscular immune serum globulin produced from plasma unscreened for anti-hepatitis C virus antibodies. Arch Intern Med 1998; 158: 807-8
72. Schiff RI. Transmission of viral infections through intravenous immune glubulin. N Engl J Mod 1994; 331: 1649-50
73. Yap PL. The viral safety of intravenous immune globulin. Clin Exp Immunol 1996; 104 Suppl. 1: 35-42
74. Piazz M in Koretz RL. Less than an ounce of prevention [see comment]. Gastroenterology 1998; 115: 234-6
75. Fattom A, Krawczynski K. Immunotherapy as a treatment for hepatitis C infection [abstract]. Evaluation in chimpanzees experimentally infected with HCV [abstract 8]. IBC's 5th Annual Conference on Hepatitis: 1999 Jan 25-26; St. Pete Reach (FL)